Clinical trials for Von Willebrand disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Von Willebrand disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Von Willebrand disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Von Willebrand disease
Title Recruitment status Location
Mild bleeding disorders caused by platelet defects Recruiting United Kingdom
VWF platelet study: a pilot study of von Willebrand factor for moderate or severe thrombocytopenia Recruiting United Kingdom
Study of Voncento® in Subjects With Von Willebrand Disease Recruiting United Kingdom
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease Recruiting United Kingdom
A clinical trial to determine the distribution through the patientâ??s body, safety and effectiveness of rVWF and rFVIII in treatment of bleeding episodes in patientâ??s diagnosed with the Von Willebrand Disease. Not Recruiting United Kingdom
Clinical study to explore the influence of the human body on the study drug, on the safety and the efficacy of recombinant VWF (in combination with recombinant FVIII and recombinant VWF alone) in the treatment of bleeding episodes in patients with von Willebrand Disease. Not Recruiting United Kingdom
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings - PRO.WILL Not Recruiting United Kingdom
Optivate in People With Von Willebrand Disease Undergoing Surgery Not recruiting United Kingdom
Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery Not recruiting United Kingdom
A Phase II single blind, randomized, placebo controlled trial to study the efficacy and safety of anti-von Willebrand factor Nanobody administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura. Not Recruiting United Kingdom

Page last reviewed: 28/08/2014

Next review due: 30/06/2017